Amylyx Pharmaceuticals
AMLX
AMLX
171 hedge funds and large institutions have $1.59B invested in Amylyx Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 62 increasing their positions, 53 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 179 → 171 (-8)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
19% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 36
Holders
171
Holding in Top 10
5
Calls
$9.02M
Puts
$1.5M
Top Buyers
| 1 | +$17.3M | |
| 2 | +$14.9M | |
| 3 | +$11M | |
| 4 |
Barclays
London,
United Kingdom
|
+$9.52M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$8.12M |
Top Sellers
| 1 | -$6.37M | |
| 2 | -$6.12M | |
| 3 | -$6.07M | |
| 4 |
PSC
Patient Square Capital
Menlo Park,
California
|
-$4.23M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$4.22M |
